Merck & Co., Inc. (MRK)
NYSE
Closed
Oct 7, 2026
Day's Range
141.4952 wk Range
82.01Overview - MRK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
401.62B
P/E (Trailing)
‪115.97‬
P/E (Forward)
‪15.08‬
PEG Ratio
‪-0.88‬
Price / Sales (TTM)
‪5.32‬
Price / Book
‪8.46‬
EV / EBITDA
‪13.91‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
2.46B
Short % of Shares Outstanding
‪1.39%‬
Held by Insiders
‪0.05%‬
Held by Institutions
‪83.05%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪142.01‬
200-Day Avg
‪122.64‬
Dividends
Payout Ratio
‪268.80%‬
Frequency
Quarterly
Analyst Consensus
27 analysts
Average price target
‪$ 148.73‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRK - Merck & Co., Inc.
Peers - MRK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- MRKNYSEMerck & Co., Inc.356.01BMarket Cap+38.46%52-week change115.98P/E (Trailing)‪4.76%‬Profit Margin
- LLYNYSEEli Lilly and Company1.05TMarket Cap+38.61%52-week change39.69P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson617.00BMarket Cap+26.51%52-week change29.74P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.464.43BMarket Cap+12.41%52-week change73.62P/E (Trailing)‪9.80%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR276.47BMarket Cap+14.68%52-week change21.97P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander, S.A. Sponsored ADR209.19BMarket Cap+28.64%52-week change14.28P/E (Trailing)‪33.46%‬Profit Margin
- NVONYSENovo Nordisk A/S Sponsored ADR164.78BMarket Cap-59.83%52-week change9.35P/E (Trailing)‪35.34%‬Profit Margin
Profile Summary - MRK - Merck & Co., Inc.
About
Merck & Co., Inc. is a global biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, biologic therapies, and animal health products. The company’s pharmaceutical business serves areas such as oncology, immunology, infectious diseases, cardiometabolic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
